SLATTERY JOSEPH P — SEC insider filings

SEC reporting owner CIK 1246530. 32 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-12-09 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Replimune Group, Inc. (REPL)Director8—2 legs · 10,400 sh · $352,5608
ImageneBio, Inc. (IMA)Director31 leg · 16,000 sh · $95,840—2
CVRx, Inc. (CVRX)Director143 legs · 8,500 sh · $71,741—44
Morphic Holding, Inc. (MORF)Director71 leg · 2,400 sh · $49,436—12

Insider filings — SLATTERY JOSEPH P

FiledFormIssuerReported transactionsSource
2026-11-104Replimune Group, Inc. (REPL)Sale (S): 5,200 @ $21.80EDGAR
2026-06-184ImageneBio, Inc. (IMA)Grant/award (A): 15,600 (derivative) @ $0EDGAR
2026-06-034CVRx, Inc. (CVRX)Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0EDGAR
2026-04-074Replimune Group, Inc. (REPL)Grant/award (A): 44,500 (derivative) @ $0EDGAR
2025-12-294ImageneBio, Inc. (IMA)Purchase (P): 16,000 @ $5.99EDGAR
2025-12-224ImageneBio, Inc. (IMA)Grant/award (A): 31,200 (derivative) @ $0EDGAR
2025-06-054CVRx, Inc. (CVRX)Grant/award (A): 19,554 (derivative) @ $0EDGAR
2025-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2024-08-204Morphic Holding, Inc. (MORF)Disposition to issuer (D): 9,066 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 9,615 (derivative) · Disposition to issuer (D): 17,550 (derivative) · Disposition to issuer (D): 12,535 (derivative) · +1 moreEDGAR
2024-08-154CVRx, Inc. (CVRX)Purchase (P): 3,000 @ $8.10EDGAR
2024-08-084CVRx, Inc. (CVRX)Purchase (P): 3,000 @ $8.24EDGAR
2024-08-064CVRx, Inc. (CVRX)Purchase (P): 2,500 @ $9.09EDGAR
2024-06-074/ACVRx, Inc. (CVRX)Grant/award (A): 27,250 (derivative) @ $0EDGAR
2024-06-064CVRx, Inc. (CVRX)Grant/award (A): 20,961 (derivative) @ $0EDGAR
2024-06-054Morphic Holding, Inc. (MORF)Grant/award (A): 23,168 (derivative) @ $0EDGAR
2024-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2024-01-024CVRx, Inc. (CVRX)Option exercise (M): 224 @ $0.24 · Option exercise (M): 1,456 @ $0.24 · Option exercise (M): 174 @ $1.19 · Option exercise (M): 96 @ $3.96 · Option exercise (M): 224 (derivative) @ $0 · Option exercise (M): 1,456 (derivative) @ $0 · +2 moreEDGAR
2023-11-144Morphic Holding, Inc. (MORF)Purchase (P): 2,400 @ $20.60EDGAR
2023-06-074CVRx, Inc. (CVRX)Grant/award (A): 12,012 (derivative) @ $0EDGAR
2023-06-024Morphic Holding, Inc. (MORF)Grant/award (A): 12,535 (derivative) @ $0EDGAR
2023-04-044Replimune Group, Inc. (REPL)Grant/award (A): 25,200 (derivative) @ $0EDGAR
2022-06-104Morphic Holding, Inc. (MORF)Grant/award (A): 17,550 (derivative) @ $0EDGAR
2022-06-094CVRx, Inc. (CVRX)Grant/award (A): 26,985 (derivative) @ $0EDGAR
2022-04-294/AMorphic Holding, Inc. (MORF)Grant/award (A): 9,615 (derivative) @ $0EDGAR
2022-04-054Replimune Group, Inc. (REPL)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2022-01-184CVRx, Inc. (CVRX)Option exercise (M): 2,149 @ $0.24 · Option exercise (M): 3,917 @ $0.24 · Option exercise (M): 316 @ $0.24 · Option exercise (M): 316 @ $0.24 · Option exercise (M): 2,528 @ $0.24 · Option exercise (M): 189 @ $0.24 · +18 moreEDGAR
2021-12-024CVRx, Inc. (CVRX)Option exercise (M): 3,000 @ $0.24 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2021-07-024CVRx, Inc. (CVRX)Grant/award (A): 5,555 @ $18EDGAR
2021-07-014CVRx, Inc. (CVRX)Grant/award (A): 10,382 (derivative) @ $0 · Grant/award (A): 9,100 (derivative) @ $0EDGAR
2021-06-174Morphic Holding, Inc. (MORF)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-04-054Replimune Group, Inc. (REPL)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2020-12-094Replimune Group, Inc. (REPL)Option exercise (M): 5,200 @ $3.30 · Sale (S): 5,200 @ $46 · Option exercise (M): 5,200 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1246530 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs